Clinical trial
YF476: Effects of Repeated Dosing at 2 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Omeprazole in Healthy Volunteers
NCT01599858 is registered in ClinicalTrials.gov with Trio Medicines Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- YF476: Effects of Repeated Dosing at 2 Dose Levels on 24-hour Ambulatory Gastric pH Compared With Placebo and Omeprazole in Healthy Volunteers
- Lead sponsor
- Trio Medicines Ltd.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 1996
- Completion date
- October 31, 1996
- Enrollment
- 49 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
reflux oesophagitis